Apotex
Apotex Inc. is a Canadian pharmaceutical corporation. Founded in 1974 by Barry Sherman, the company is the largest producer of generic drugs in Canada, with annual sales exceeding CA$1 billion. By 2016, Apotex employed over 10,000 people as one of Canada's largest drug manufacturers, with over 300 products selling in over 115 countries. Revenues were about CA$1.19 billion annually. Apotex manufactures and distributes generic medications for a range of diseases and health conditions that include cancer, diabetes, high cholesterol, glaucoma, infections and blood pressure.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Abacavir | Abacavir | 2012-12-17 | 2027-2029 | |
| Abiraterone | Abiraterone | 2018-10-31 | 2027-2038 | |
| Acyclovir | Acyclovir | 2005-09-28 | 2027-2030 | |
| Adefovir dipivoxil | Adefovir dipivoxil | 2018-07-06 | — | |
| Albuterol | Albuterol | 2007-02-02 | 2024-2041 | |
| Albuterol ipratropium | Albuterol, Ipratropium | 2007-12-31 | 2024-2041 | |
| Alendronate | Alendronate | 2008-08-04 | 2031 | |
| Alfuzosin | Alfuzosin | 2011-07-18 | ||
| Alkeran | Melphalan | 1982-01-01 | 2029-2036 | |
| Alprazolam | Alprazolam | 2007-01-19 |
1
2
3
4
5
6
...
21
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use